Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in the United States, Symphony Alpha Ventures is a venture capital firm dedicated to early-stage healthcare IT companies. The firm partners with promising healthcare technology startups that possess strong entrepreneurial teams and the potential for recurring SaaS revenues. Symphony Alpha Ventures leverages its parent company, Symphony Corporation, to facilitate the development and commercialization of healthcare solutions.
Over the years, Symphony Alpha Ventures has established a strong presence in the healthcare technology sector, focusing on investments that enhance workflow and improve healthcare delivery. The firm has successfully facilitated multiple exits, showcasing its ability to identify and nurture high-potential startups. Their commitment to supporting innovative healthcare solutions has positioned them as a key player in the early-stage investment landscape.
Symphony Alpha Ventures invests primarily in early-stage healthcare technology companies, particularly those that utilize innovative technologies to enhance workflow and improve healthcare delivery. The firm targets companies with a minimum viable product (MVP) and emphasizes SaaS models that leverage cloud-based technologies. Their investment strategy encompasses capital investment, product development support, and strategic partnerships to help companies refine their business models and accelerate market penetration.
The firm is particularly interested in startups that demonstrate strong potential for recurring revenue and have a clear path to market. Symphony Alpha Ventures seeks to partner with founders who possess a deep understanding of their market and a commitment to driving innovation in healthcare technology. Their focus on healthcare and SaaS sectors allows them to provide tailored support and resources to their portfolio companies.
Symphony Alpha Ventures has a notable track record of successful exits in the healthcare technology sector. Key exits include:
Additionally, Symphony Alpha Ventures developed the SymphonyCare technology platform, which was acquired by Influence Health to enhance their patient engagement offerings. They also contributed to the development of products for Liazon Corporation, which was acquired for $215 million by Towers Watson in November 2013, and Symphony Data Corporation, acquired by Zavata in 2005.
Ravi Kalla - Managing Director. Ravi has extensive experience in venture capital and healthcare technology, having previously worked with several notable firms in the industry. He has led investments in multiple successful startups and has a strong background in operational management.
Tom Carmona - Managing Director. Tom brings a wealth of knowledge in healthcare IT and venture capital, with a track record of identifying high-potential startups. His expertise includes product development and market strategy, making him a valuable asset to the firm and its portfolio companies.
In August 2022, Symphony Alpha Ventures celebrated the acquisition of Starchup by Cents, marking a significant exit for the firm. Similarly, ReviewTrackers was acquired by InMoment in June 2022, and Hitch Works was acquired by ServiceNow in the same month, showcasing the firm's successful track record in the healthcare technology sector.
Additionally, Symphony Alpha Ventures developed the SymphonyCare technology platform, which was acquired to enhance patient engagement offerings. Their involvement in the development of products for Liazon Corporation and Symphony Data Corporation further highlights their active role in the healthcare technology landscape.
What investment criteria does Symphony Alpha Ventures look for?
Symphony Alpha Ventures focuses on early-stage healthcare technology companies with a minimum viable product (MVP) and a strong potential for recurring SaaS revenues. They prioritize startups that leverage innovative technologies to enhance workflow and improve healthcare delivery.
How can I pitch to Symphony Alpha Ventures?
Founders can pitch their startups by reaching out directly through their website or via email. It is recommended to include a detailed business plan, product information, and market analysis in the pitch deck.
What makes Symphony Alpha Ventures different from other investors?
The firm leverages its parent company, Symphony Corporation, to provide additional resources and support for product development and commercialization, which sets them apart from many other venture capital firms.
What is the geographic focus of Symphony Alpha Ventures?
Symphony Alpha Ventures primarily invests in companies based in the United States, focusing on the healthcare technology sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Symphony Alpha Ventures invests in early-stage rounds, including pre-seed, seed, and seed-plus stages, indicating a focus on smaller, initial investments.
What kind of support do portfolio companies receive post-investment?
Symphony Alpha Ventures provides product development support, strategic partnerships, and guidance to help portfolio companies refine their business models and accelerate market penetration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.